Abstract: Synthetic nucleic acids are described that can be used for astrocyte-directed expression of heterologous nucleotide sequences. Also described are methods of using the same for astrocyte-directed expression of such nucleotide sequences for the treatment of neurodegenerative diseases.
| # | Name | Date |
|---|---|---|
| 1 | 202517055396-STATEMENT OF UNDERTAKING (FORM 3) [09-06-2025(online)].pdf | 2025-06-09 |
| 3 | 202517055396-Sequence Listing in PDF [09-06-2025(online)].pdf | 2025-06-09 |
| 4 | 202517055396-REQUEST FOR EXAMINATION (FORM-18) [09-06-2025(online)].pdf | 2025-06-09 |
| 5 | 202517055396-POWER OF AUTHORITY [09-06-2025(online)].pdf | 2025-06-09 |
| 6 | 202517055396-FORM 18 [09-06-2025(online)].pdf | 2025-06-09 |
| 7 | 202517055396-FORM 1 [09-06-2025(online)].pdf | 2025-06-09 |
| 8 | 202517055396-DRAWINGS [09-06-2025(online)].pdf | 2025-06-09 |
| 9 | 202517055396-DECLARATION OF INVENTORSHIP (FORM 5) [09-06-2025(online)].pdf | 2025-06-09 |
| 10 | 202517055396-COMPLETE SPECIFICATION [09-06-2025(online)].pdf | 2025-06-09 |
| 11 | 202517055396-CLAIMS UNDER RULE 1 (PROVISIO) OF RULE 20 [09-06-2025(online)].pdf | 2025-06-09 |
| 12 | 202517055396-FORM 3 [13-11-2025(online)].pdf | 2025-11-13 |